Ad
related to: canadian drug companies
Search results
Is Tilray Stock A Buy After Biden Tweets About Pot Reclassification?
Investor's Business Daily· 6 hours agoOther Canadian marijuana stocks also have mediocre or weak profit ratings as they continue to lose...
IBEX011, the first Nagoya-compliant GMP iboga extract, is now available for clinical use and...
Rome Sentinel· 1 day agoToday, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP...
AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters
Investing.com· 7 hours agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier...
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Digital Journal· 9 hours agoAlgernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development ...
I'm a Canadian who's lived in the US for over 30 years. I don't get why so many Americans want to...
Business Insider via Yahoo News· 3 days agoI don't see why Canada is so appealing to Americans Canada used to be an admired country worldwide,...
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
Digital Journal· 7 hours agoThese statements appear in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company< ...
FDA sued by scientist urging sexual side effects warning for widely used depression drugs
Reuters· 1 day agoA Howard University scientist on Monday sued the U.S. Food and Drug Administration for failing to...
Mike Sofia, who discovered cure for hepatitis C, set to retire from Arbutus Biopharma - Philadelphia...
The Business Journals· 4 days agoNot many scientists get a drug named after them, but Mike Sofia did. When he departs, he will cap a...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 6 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
Pot Stocks Surge as Biden ‘Reschedules’ Marijuana
Barrons.com· 5 days agoIts stock shot up 15%, to $11.95, after the 1 p.m. tweet from the White House. But the Canadian firm doesn’t yet sell weed in the U.S. Instead, it has...